FORMULATION AND EVALUATION OF CONTROLLED RELEASE OSMOTIC TABLET OF METOPROLOL SUCCINATE
Objective: Metoprolol Succinate has a short elimination half- life (3-7 hours) and rapidly absorbed in GIT If it is formulated by conventional tablets requires multiple daily administration with resulting inconvenience to the hypertensive patient and the possibility of reduced compliance with prescribed therapy. Methods: Core tablets were prepared by direct compression technique using fructose and KCl as osmogens and Avicel PH101 as filler. The core tablets were coated by dip coating and used a coating agent cellulose acetate (2%w/v) with PEG400 and PEG6000 as water soluble pore former and dibutyl-pthalate as plasticizer. The optimized formulation was evaluated for Compatibility Study by FTIR, invitro drug release study by USP-II dissolution apparatus and, accelerated stability study. Results: Optimized batch FaC3 was formulated using ratio 3:2 (Fructose : KCl) ofÂ osmogent mixture, 20% w/w of pore former(PEG6000) and 4% weight gain. It gave about 97.59 % drug release for 12 hours. The highest r2 value (0.979) through zero order drug release and nâ‰ˆ0.982 indicates case-II transport or typical zero-order. Optimized formulation had no significant effect on pH, agitational intensity and found to be compatible with the excipients and stable. Before contact with the dissolution medium, SEM images revealed that no pores were observed before dissolution and after dissolution had shown the porous nature of the membrane. Conclusion: The present study confirmed that the drug release inversely proportional to membrane weight gain and release increases with mixture of osmogens and system provides a controlled release.
Gupta PB, Thakur N, Jain PN, Banweer J and Jain S. Osmotically Controlled Drug Delivery System with Associated Drugs. J Pharm Pharmaceut Sci 2010; 13(3): 571-588.
Babu A, Rao PM and Vijaya RJ. Controlled Porosity Osmotic Pump Tablets. J Pharm Res H 2010; 2(1): 114-126.
Verma RK, Mishra B and Garg S. Osmotically Controlled Oral Drug Delivery. Drug Dev Ind Pharm 2000; 26(7): 695-708.
Malaterre V, Ogorka J, Loggia N and Gurny R. Oral Osmotically Driven Systems: 30 years of development and clinical use. Eur J Pharma Biopharm 2009; 73: 311-323.
Herrlich S, Speith S, Messner S and Zengerle R. Osmotic Micropumps for Drug Delivery. Adv Drug Deliv Rev 2012; 64: 1617-1627.
Wei L, Li J, Guo L, Nie S and Pan W. Investigations of a Novel Self-Emulsifying Osmotic Pump Tablet Containing Carvedilol. Drug Dev Ind Pharm 2007; 33:990-998.
Rani M and Mishra B. Comparative In Vitro and In Vivo Evaluation of Matrix, Osmotic Matrix, and Osmotic Pump Tablets for Controlled Delivery of Diclofenac Sodium. AAPS Pharm Sci Tech 2004; 5(4).
Sathyaraj A and Abhinav K. Formulation and Evaluation of Metoprolol Succinate Controlled Release Tablets Using Natural and Synthetic Polymer. Int J Pharm Sci Res 2012; 3(1): 247-256.
Kumar P, Singh S, Mishra B. Gastroretentive Drug Delivery System of Ranitidine Hydrochloride Based on Osmotic Technology: Development and Evaluation. Curr Drug Deliv 2008; 5: 332â€“342.
Diwedi R, Alexander S and Chandrashekar MJN. Preparation and InVitro Evaluation of Sustained Release TabletFormultions of Metformin HCl. Asian J Pharm Clin Res 2012; 5(1): 45-48.
Khan AZ, Tripathi R and Mishra B. Floating Elementary Osmotic Pump Tablet (FEOPT) for Controlled Delivery of Diethylcarbamazine Citrate: a Water-Soluble Drug. AAPS Pharm Sci Tech 2011; 12(4).
Khan HZ, Tripathi R and Mishra B. Design and Evaluation of Entric Coated Microporous Osmotic Pump Tablet of Quietiapine Fumarate for the Treatment of Psychosis. Acta Pol Pharmaceu-Dru Res 2012; 69(6): 1125-1136.
Bhoopathi GS, Jayanthi, Pramoda G and Srikanth S. Formulation and InVitro Evaluation of sustained release matrix tablets of furosemide. Wrd J Pharm Pharmceu Sci 2013; 2(6): 5052-5066.
Lachman L. The Theory and Practice of Industrial Pharmacy. 3rd ed. Bombay: Varghese Publishing House; 1987.
Dansankoppa FS, Ningangowder M and Sholapur S. Formulation and Evaluation of Controlled Porosity Osmotic Pump for Oral Delivery of Ketorolac. J Bas Clin Pharm 2013; 4(1).
Rao BP, Geetha M, Purushothama N and Sanki U. Optimization and Development of Swellable Controlled Porosity Osmotic Pump Tablet for Theophylline. Tro J Pharma Res 2009; 8(3): 247-255.
Sambath L, Kottai MA and Kumar AM. Soluplus Complexation Influence the Release of Lovastatin From Porous Osmotic Pump Tablet. Wrd J Pharm Pharmceu Sci 2013; 2(5).
Costa P, Lobo JMS. Modeling and Comparison of Dissolution Profiles. Eur J Pharm Sci 2001; 13: 123â€“133.
Goyal A, Shukla P and Srivastava AK. Factors Inflencing Drug Release Characteristics From Hydrophilic Polymer Matrix Tablet. Asian J Pharm Clin Res 2009; 2(1): 93-98.
Kumaravelrajan R, Narayanan N and Suba V. Development and Evaluation of Controlled Porosity Osmotic Pump for Nifedipine and Metoprolol Combination. Lipids Heal Dis 2011; 10(51).
Kumar P, Singh S and Mishra B. Development and Biopharmaceutical Evaluation of Extended Release Formulation of Tramadol Hydrochloride Based on Osmotic Technology. Acta Pharma 2009; 59: 15-30.
Garg A, Gupta M and Bhargava NH. Effect of Formulation Parameters on the Release Characteristics of Propranolol from Asymmetric Membrane Coated Tablets. Eur J Pharma Biopharm 2007; 67: 725-731.
Mahalaxmi R, Sastri P , Atin K and Kanagale P. Enhancement of Dissolution of Glipizide from Controlled Porosity Osmotic Pump Using A Wicking Agent and A Solubilizing Agent. Int J Pharm Tech Res 2009; 1(3): 705-711.
Prajapati ST, Patel AN and Patel CN. Formulation and Evaluation of Controlled-Release Tablet of Zolpidem Tartrate by Melt Granulation Technique. Int Sch Res Net Pharm 2011: 1-8.
Vranic E and Uzunovic A. Inflence of Splitting on Dissolution Properties of Metoprolol Tablets. Bosn J Bas Med Sci 2009; 9(3): 245-249.
Prabhakaran D, Singh P, Jaganathan KS and Vyas SP. Osmotically Regulated Symmetric Capsular Systems for Simultaneous Sustained Delivery of Anti-Tubercular Drugs. J Cont Rel 2004; 9: 239-248.
Liu L, Wang J and Zhu S. Delivery of Prazosin Hydrochloride from Osmotic Pump System Prepared by Coating the Core Tablet with an Indentation. Drug Deliv 2007; 14: 219-224.
Patel RB, Patel GN, Patel HR and Patel MM. Inlay Osmotic Pump Tablets Containing Metformin and Glipizide. Drug Dev Ind Pharm 2011; 37(10): 1244-1252.
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.